Amebiasis

Preface. - 1 Introduction. - 2 The continuously expanding universe of Entamoeba. - 3 The genomics of Entamoebae: insights and challenges. - 4 Multilocus sequence typing system (MLST): Genetic diversity and genetic components to virulence. - 5 The tRNA gene-linked STRs and other genetic typing methods. - 6 Genetic manipulation techniques. - 7 Surveying Entamoeba histolytica transcriptome using massively parallel cDNA sequencing. - 8 Ribosomal RNA Genes and their Regulation in Entamoeba histolytica. - 9 Small RNAs and regulation of gene expression in Entamoeba histolytica. - 10 The Biology of Retrotransposition in Entamoeba histolytica. - 11 Entamoeba histolytica: Bridging the gap between environmental stress and epigenetic regulation. - 12 Phagocytosis in Entamoeba histolytica. - 13 Signalling pathways in E. histolytica. - 14 Transmembrane Kinases and their role in E. histolytica pathogenesis. - 15 Cell surface molecules as virulence determinants in Entamoeba histolytica. - 16 Mechanism of cell division in Entamoeba histolytica. - 17 Molecular basis of the trafficking of cysteine proteases and other soluble lysosomal proteins in Entamoeba histolytica. - 18 Mitosomes in Entamoeba histolytica. - 19 Metabolomic analysis of Entamoeba biology. - 20 Glucose metabolism and its controlling mechanisms in Entamoeba histolytica. - 21 Structural Biology of Cysteine Biosynthetic Pathway Enzymes. - 22 Archetypical and specialized DNA replication proteins in Entamoeba histolytica. - 23 Pathology, pathogenesis and experimental amebiasis. - 24 Innate Host Defenses in the Gut. - 25 Cysteine peptidases in pathogenesis. - 26 Host immunity and tissue destruction during liver abscess formation. - 27 The Effect of E. histolytica on Muc2 Mucin and Intestinal Permeability. - 28 Human Genetic Susceptibility to Amebiasis. - 29 Immune Response in Human Amoebiasis: a protective response? . - 30 Metronidazole and the Redox Biochemistry of Entamoeba histolytica. - 31 Thioredoxin Reductase and its Role as a New Drug Target. - 32 Drug development: old drugs and new lead. - 33 HETEROCYCLIC LEAD COMPOUNDS AGAINST AMOEBIASIS